Similar articles

• [Fenquizone in the medium term treatment of essential hypertension. Double-blind comparison with chlorthalidone and placebo].

  Pasotti C, Rossi R, Gandolfi P. Pasotti C, et al. Minerva Med. 1981 Nov 17;72(46):3105-10. Minerva Med. 1981. PMID: 7029355 Clinical Trial. Italian.
• Double-blind crossover study of fenquizone compared to chlorthalidone in essential hypertension.

  Angelino PF, Alvino-Demartino A, Mappa R, Donati C. Angelino PF, et al. Int J Clin Pharmacol Ther Toxicol. 1985 Sep;23(9):501-5. Int J Clin Pharmacol Ther Toxicol. 1985. PMID: 3902676 Clinical Trial.
• [Clinical trial of the activity and therapeutic effectiveness of 3 drugs with diuretic and antihypertensive action].

  Tiberi F, Corinaldesi G. Tiberi F, et al. Minerva Med. 1981 Jan 21;72(2):95-100. Minerva Med. 1981. PMID: 7007928 Clinical Trial. Italian.
• [Prazosin in moderate or severe essential arterial hypertension not controlled with chlorthalidone. A multicenter study].

  Saldanha RV, Macruz R, Santana PC, de Lima JJ, Zalc S, Pileggi F. Saldanha RV, et al. Arq Bras Cardiol. 1983 Jun;40(6):433-8. Arq Bras Cardiol. 1983. PMID: 6667153 Portuguese. No abstract available.
• [Treatment of arterial hypertension: comparative study of atenolol + chlorthalidone vs. timolol maleate-hydrochlorthiazide-amiloride association].

  Brandão AP, Oigman W, Albanesi Filho FM. Brandão AP, et al. Arq Bras Cardiol. 1981 Dec;37(6):495-8. Arq Bras Cardiol. 1981. PMID: 7347202 Portuguese. No abstract available.